Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa

Lignende værker

• Early outcomes and the virologic impact of delayed treatment switching on second-line therapy in an antiretroviral roll-out program in South Africa
  af: Levison, Julie H., et al.
  Udgivet: (2011)
• Resistance in Pediatric Patients Experiencing Virologic Failure with First- and Second-Line Antiretroviral Therapy
  af: Orrell, Catherine, et al.
  Udgivet: (2013)
• Virologic failure and second-line antiretroviral therapy in children in South Africa - The IeDEA Southern Africa Collaboration
  af: Davies, Mary-Ann, et al.
  Udgivet: (2011)
• The Survival Benefits of Antiretroviral Therapy in South Africa
  af: April, Michael D., et al.
  Udgivet: (2014)
• The Clinical and Economic Impact of Genotype Testing at First-line Antiretroviral Therapy Failure for HIV-Infected Patients in South Africa
  af: Levison, Julie H., et al.
  Udgivet: (2013)